(Q35128994)

6 August 2017

1 reference

title

The role of carnitine in normal and altered fatty acid metabolism (English)

1 reference

6 August 2017

0 references

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00112-4

3 January 2024

author name string

Charles Hoppel

1

1 reference

6 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12751049

3 January 2024

publication date

1 April 2003

1 reference

full work available at URL

6 August 2017

https://api.elsevier.com/content/article/PII:S0272638603001124?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00112-4

https://api.elsevier.com/content/article/PII:S0272638603001124?httpAccept=text/plain

3 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00112-4

American Journal of Kidney Diseases

3 January 2024

published in

1 reference

6 August 2017

volume

41

1 reference

6 August 2017

issue

4 Suppl 4

1 reference

6 August 2017

page(s)

S4-12

1 reference

Carnitine--metabolism and functions

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

1 reference

7 January 2021

Carnitine metabolism and function in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Carnitine metabolism and its regulation in microorganisms and mammals

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Genetic disorders of carnitine metabolism and their nutritional management

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Kinetic compartmental analysis of carnitine metabolism in the human carnitine deficiency syndromes. Evidence for alterations in tissue carnitine transport

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Hepatic synthesis of carnitine from protein-bound trimethyl-lysine. Lysosomal digestion of methyl-lysine-labelled asialo-fetuin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Effect of starvation on the disposition of free and peptide-linked trimethyllysine in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

1 reference

7 January 2021

Inter-tissue relationships in the synthesis and distribution of carnitine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Metabolism and excretion of carnitine and acylcarnitines in the perfused rat kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Pathway of alpha-linolenic acid through the mitochondrial outer membrane in the rat liver and influence on the rate of oxidation. Comparison with linoleic and oleic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Fatty acid import into mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

1 reference

7 January 2021

Regulation of the long-chain carnitine acyltransferases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Relationship between acid-soluble carnitine and coenzyme A pools in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Effect of carnitine on mitochondrial oxidation of palmitoylearnitine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Carnitine and acylcarnitine metabolism during exercise in humans. Dependence on skeletal muscle metabolic state

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Uptake, metabolism and release of carnitine and acylcarnitines in the perfused rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Isolation and identification of alpha-methyloctanylcarnitines from human urine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Effects of propionate and carnitine on the hepatic oxidation of short- and medium-chain-length fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

The involvement of carnitine intermediates in peroxisomal fatty acid oxidation: a study with 2-bromofatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Measurement of peroxisomal fatty acid beta-oxidation in cultured human skin fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

The role of the carnitine system in peroxisomal fatty acid oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Effect of carnitine and branched-chain acylcarnitines on the 2-oxo acid dehydrogenase activity in intact mitochondria of rat muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Formation and excretion of branched-chain acylcarnitines and branched-chain hydroxy acids in the perfused rat kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Stabilizing action of L-carnitine on the energy-linked processes of mitochondria isolated from perfused rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Involvement of long-chain acyl CoA in the antagonistic effects of halothane and L-carnitine on mitochondrial energy-linked processes.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Normalization of short-chain acylcoenzyme A dehydrogenase after riboflavin treatment in a girl with multiple acylcoenzyme A dehydrogenase-deficient myopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Long-chain acyl coenzyme A dehydrogenase deficiency: an inherited cause of nonketotic hypoglycemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Defective myocardial carnitine metabolism in congestive heart failure secondary to dilated cardiomyopathy and to coronary, hypertensive and valvular heart diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Three-year survival of patients with heart failure caused by dilated cardiomyopathy and L-carnitine administration

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Mitochondrial dysfunction in ischaemia-reperfusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Effect of L-Carnitine on the Cellular Distribution of Carnitine and Its Acyl Derivatives in the Ischemic Heart

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Increased malondialdehyde in peripheral blood of patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Suppression of T(3)- and fatty acid-induced membrane permeability transition by L-carnitine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Roles of long chain fatty acids and carnitine in mitochondrial membrane permeability transition

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Insulin receptor autophosphorylation and signaling is altered by modulation of membrane physical properties.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Relation of functional capacity with the oxidative stress and antioxidants in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Plasma lipophilic antioxidants and malondialdehyde in congestive heart failure patients: relationship to disease severity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

L-carnitine in dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Effects of L-carnitine administration on short-chain fatty acid (acetic acid) and long-chain fatty acid metabolism during hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Effects of L-carnitine on arrhythmias during hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Plasma and muscle carnitine levels in haemodialysis patients with morphological-ultrastructural examination of muscle samples

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Improvement of myocardial fatty acid metabolism through L-carnitine administration to chronic hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Oxidative stress and cardiovascular disease in dialyzed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Oxidative stress and inflammation in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Fatty acid oxidation in the myocardium: effects of parathyroid hormone and CRF.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Carnitine metabolism during exercise in patients on chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

The role of L-carnitine in the pathogenesis of cardiomegaly in patients with chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Effects of L-carnitine supplementation on renal anemia in poor responders to erythropoietin.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Correlation between serum carnitine levels and erythrocyte osmotic fragility in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Pharmacokinetic considerations for the therapeutic use of carnitine in hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

l-Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900112-4

7 January 2021

Biosynthesis and metabolism of carnitine

37

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00112-4

The role of carnitine in intracellular metabolism

3 January 2024

38

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00112-4

Carnitine metabolism and deficiency syndromes

3 January 2024

40

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00112-4

Selected metabolic alterations in the ischemic heart and their contributions to arrhythmogenesis

3 January 2024

51

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00112-4

Effect of protection and repair of injury of mitochondrial membrane-phospholipid on prognosis in patients with dilated cardiomyopathy

3 January 2024

57

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00112-4

Does treatment of renal anemia with recombinant erythropoietin influence oxidative stress in hemodialysis patients?

3 January 2024

67

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00112-4

Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients

3 January 2024

68

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00112-4

The therapeutic potential of carnitine in cardiovascular disorders

3 January 2024

73

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00112-4

3 January 2024

Identifiers

1 reference

6 August 2017

1 reference